Cancer Center

The drug, when paired with a chemotherapy regimen, was even more effective in fighting ovarian cancer in cell lines in which signaling of the Src family kinases, associated with the deadly disease, is activated.

The study appears in the Nov. 10, 2009 edition of the British Medical Journal.

Ovarian cancer, which will strike 21,600 women this year and kill 15,500, causes more deaths than any other cancer of the female reproductive system. Few effective therapies for ovarian cancer exist, so it would be advantageous for patients if a new drug could be found that fights the cancer, said Gottfried Konecny, an assistant professor of hematology/oncology, a Jonsson Cancer Center researcher and first author of the study.

» Read more: FDA Approved Leukemia Drugs Shows Promise In Ovarian Cancer Cells

Related posts

• US Cancer Costs Double in Nearly 20 Years
• Pink rink makes fans think, raises money to fight cancer
• The Dries Cancer Diet: A Practical Guide to the Use of Fresh Fruit and Raw Vegetables in the Treatment of Cancer
• Healing Cancer
• Vitamins and Cervix Or Prostrate Cancer